封面
市場調查報告書
商品編碼
1869706

精準醫療軟體市場規模、佔有率和趨勢分析報告:按組件、部署、應用、技術、治療領域、最終用途、地區和細分市場預測(2025-2033 年)

Precision Medicine Software Market Size, Share & Trends Analysis Report By Component, By Deployment, By Application, By Technology, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

精準醫療軟體市場摘要

預計到 2024 年,全球精準醫療軟體市場規模將達到 21.2 億美元,到 2033 年將達到 56.6 億美元。

預計從 2025 年到 2033 年,其複合年成長率將達到 11.8%。這一成長是由基因測序成本下降、標靶治療的廣泛採用、分散式臨床試驗的興起以及真實世界數據 (RWE) 的使用所推動的。

此外,政府和機構對基因組學和精準醫療的支持舉措,以及對個人化醫療的需求,都在推動該產業的發展前景。基因測序成本的下降使其從高成本的、僅用於研究的工具轉變為臨床實踐中的常規手段,並成為精準醫療軟體產業的主要驅動力。 21世紀初,每個基因組的定序成本約為1億美元,而現在不到500美元,這使得醫院、診斷檢查室、製藥公司甚至消費者保健公司都能廣泛採用這項技術。

這種經濟實惠的檢測方式推動了大規模基因組檢測的爆炸性成長,產生了大量資料集,需要複雜的軟體來儲存、整合和解讀這些資料。精準醫療軟體在將這些原始數據(序列數據)轉化為可用於診斷、治療選擇和患者分層的臨床資訊方面發揮著核心作用,隨著測序在腫瘤學、罕見疾病治療和預防保健領域逐漸成為標準流程,對精準醫療軟體的需求也隨之成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業機會分析
    • 產業問題分析
    • 技術概述
    • 案例研究
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析

第4章 精準醫療軟體市場:組成部分估算與趨勢分析

  • 組件細分儀表板
  • 2024 年及 2033 年零件市佔率變化分析
  • 按組件分類的市場規模、預測和趨勢分析,2021-2033 年
  • 軟體
  • 服務
    • 實施與整合
    • 臨床解釋和報告服務
    • 檢驗和監管支持
    • 資料整理/標註服務
    • 其他

第5章 精準醫療軟體市場:部署模式估算及趨勢分析

  • 部署模式儀錶板
  • 部署模式市佔率變化分析(2024 年和 2033 年)
  • 按部署模式分類的市場規模、預測與趨勢分析,2021-2033年
  • 雲端基礎的
  • 本地部署

第6章 精準醫療軟體市場:應用預測與趨勢分析

  • 應用細分儀表板
  • 應用市佔率變化分析,2024 年和 2033 年
  • 市場規模、預測與趨勢分析(按應用領域分類,2021-2033 年)
  • 基因組資料管理與分析
  • 多體學分析
  • 臨床決策支援和治療計劃
  • 伴隨診斷和生物標記發現工具
  • 臨床試驗配對和中心選擇
  • 其他(人群基因體學/公共衛生精準工具)

第7章 精準醫療軟體市場:技術預測與趨勢分析

  • 技術儀錶板
  • 2024 年及 2033 年技術市佔率變化分析
  • 市場規模、預測與趨勢分析(按技術分類,2021-2033 年)
  • 人工智慧/機器學習模型和生成式人工智慧
  • 基於規則的引擎(臨床指引、路徑)
  • 雲端和容器化管道(Kubernetes/Docker)
  • 基因組學高效能運算/HPC
  • 互通性/FHIR/HL7整合
  • 其他(資料湖和 MDM(多模態資料儲存))

第8章 精準醫療軟體市場:治療領域估算與趨勢分析

  • 治療領域儀表板
  • 2024 年及 2033 年治療領域市佔率變化分析
  • 按治療領域分類的市場規模、預測和趨勢分析(2021-2033 年)
  • 腫瘤學
  • 心臟病學
  • 神經病學/中樞神經系統
  • 罕見疾病和遺傳疾病
  • 感染疾病(病原體基因體學)
  • 免疫學/自體免疫
  • 其他科室(皮膚科、內分泌科)

第9章 精準醫療軟體市場:終端使用者估算與趨勢分析

  • 最終用戶細分儀表板
  • 2024 年及 2033 年最終用戶市佔率變化分析
  • 按最終用途分類的市場規模、預測和趨勢分析(2021-2033 年)
  • 醫院
  • 製藥和生物技術公司
  • 診斷實驗室和基因組學服務供應商
  • 受託研究機構(CRO)
  • 其他(研究機構和學術中心)

第10章 精準醫療軟體市場:區域估算與趨勢分析

  • 區域市場概覽
  • 區域市場:主要結論
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第11章 競爭格局

  • 參與者概覽
  • 企業市場分析/企業市佔率分析(2024 年)
  • 公司分類
  • 策略規劃
  • 公司簡介
    • OSP
    • Genomind
    • IQVIA
    • Genedata AG
    • SOPHiA GENETICS
    • Tempus AI, Inc.
    • Owkin, Inc.
    • Syapse(acquired by N-Power in January 2025)
    • Inspirata, Inc.
    • Precision Medicine Group, LLC.
    • Siemens
    • GenomOncology LLC
    • Qserve
    • Foundation Medicine, Inc.
    • PierianDx
Product Code: GVR-4-68040-759-3

Precision Medicine Software Market Summary

The global precision medicine software market size was valued at USD 2.12 billion in 2024 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 11.8% from 2025 to 2033. This growth is attributed to declining cost of genome sequencing, rise of targeted and personalized therapies, the increase of decentralized trials, and real-world evidence.

Moreover, government and institutional initiatives supporting genomics and precision medicine, and demand for personalized healthcare, have fueled the industry outlook. The declining cost of genome sequencing has transformed it from a high-cost, research-only tool into a routine part of clinical practice, making it a key driver of the precision medicine software industry. What once cost nearly USD 100 million per genome in the early 2000s can now be performed for under USD 500, enabling widespread adoption by hospitals, diagnostic labs, pharmaceutical companies, and even consumer health firms.

This affordability has led to a surge in large-scale genomic testing, generating massive datasets that require advanced software for storage, integration, and interpretation. Precision medicine software plays a central role in converting this raw sequencing data into actionable clinical insights for diagnosis, therapy selection, and patient stratification, driving demand as sequencing becomes standard in oncology, rare disease treatment, and preventive healthcare.

Global Precision Medicine Software Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global precision medicine software market report based on component, deployment mode, application, technology, therapeutic area, end use and region.

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services
    • Implementation & integration
    • Clinical interpretation & reporting services
    • Validation & regulatory support
    • Data curation / annotation services
    • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloud-based
  • On-premise
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Genomic Data Management & Analysis
  • Multi-omics Analytics
  • Clinical Decision Support & Treatment Planning
  • Companion Diagnostics & Biomarker Discovery Tools
  • Clinical Trial Matching & Site Selection
  • Others (Population Genomics / Public-health Precision Tools)
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • AI / Machine Learning models & Generative AI
  • Rule-based engines (clinical guidelines, pathways)
  • Cloud & Containerized Pipelines (Kubernetes/Docker)
  • High-performance compute / HPC for genomics
  • Interoperability / FHIR / HL7 integration
  • Others (Data lakes & MDM (multi-modal data stores))
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiology
  • Neurology / CNS
  • Rare & Genetic Disorders
  • Infectious Diseases (pathogen genomics)
  • Immunology / Autoimmune
  • Others (dermatology, endocrinology)
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Pharmaceutical & Biotech companies
  • Diagnostic Laboratories & Genomic Service Providers
  • Contract Research Organizations (CROs)
  • Others (Research Institutes & Academic Centers)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Component
    • 1.2.2. Deployment Mode
    • 1.2.3. Application
    • 1.2.4. Technology
    • 1.2.5. Therapeutic Area
    • 1.2.6. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Declining Cost of Genome Sequencing
      • 3.2.1.2. Shift toward value-based and personalized care
      • 3.2.1.3. Government and institutional initiatives supporting genomics and precision medicine
      • 3.2.1.4. Rising patient awareness and demand for personalized healthcare
      • 3.2.1.5. Maturing interoperability standards (FHIR, GA4GH, HL7)
      • 3.2.1.6. Advances in AI and machine learning
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High implementation and maintenance costs
      • 3.2.2.2. Integration challenges with legacy electronic health records
      • 3.2.2.3. Shortage of skilled professionals in bioinformatics, genomics, and data science.
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Technology Overview
    • 3.2.6. Case Studies
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Precision Medicine Software Market: Component Estimates & Trend Analysis

  • 4.1. Component Segment Dashboard
  • 4.2. Component Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Implementation & integration
      • 4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Clinical interpretation & reporting services
      • 4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Validation & regulatory support
      • 4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Data curation / annotation services
      • 4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Precision Medicine Software Market: Deployment Mode Estimates & Trend Analysis

  • 5.1. Deployment Mode Dashboard
  • 5.2. Deployment Mode Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
  • 5.4. Cloud Based
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. On-Premise
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Precision Medicine Software Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Application Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Genomic Data Management & Analysis
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Multi-omics Analytics
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Clinical Decision Support & Treatment Planning
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Companion Diagnostics & Biomarker Discovery Tools
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Clinical Trial Matching & Site Selection
    • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Others (Population Genomics / Public-health Precision Tools)
    • 6.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Precision Medicine Software Market: Technology Estimates & Trend Analysis

  • 7.1. Technology Dashboard
  • 7.2. Technology Market Share Movement Analysis, 2024 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 7.4. AI / Machine Learning models & Generative AI
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Rule-based engines (clinical guidelines, pathways)
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Cloud & Containerized Pipelines (Kubernetes/Docker)
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. High-performance compute / HPC for genomics
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Interoperability / FHIR / HL7 integration
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Others (Data lakes & MDM (multi-modal data stores))
    • 7.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Precision Medicine Software Market: Therapeutic Area Estimates & Trend Analysis

  • 8.1. Therapeutic Area Dashboard
  • 8.2. Therapeutic Area Market Share Movement Analysis, 2024 & 2033
  • 8.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
  • 8.4. Oncology
    • 8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Cardiology
    • 8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Neurology / CNS
    • 8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Rare & Genetic Disorders
    • 8.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Infectious Diseases (pathogen genomics)
    • 8.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.9. Immunology / Autoimmune
    • 8.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.10. Others (dermatology, endocrinology)
    • 8.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Precision Medicine Software Market: End Use Estimates & Trend Analysis

  • 9.1. End Use Segment Dashboard
  • 9.2. End Use Market Share Movement Analysis, 2024 & 2033
  • 9.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 9.4. Hospitals
    • 9.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Pharmaceutical & Biotech companies
    • 9.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Diagnostic Laboratories & Genomic Service Providers
    • 9.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. Contract Research Organizations (CROs)
    • 9.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8. Others (Research Institutes & Academic Centers)
    • 9.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Precision Medicine Software Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Dashboard
  • 10.2. Regional Market: Key Takeaways
  • 10.3. North America
    • 10.3.1. North America Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.3.2. U.S.
      • 10.3.2.1. Key country dynamic
      • 10.3.2.2. Regulatory framework
      • 10.3.2.3. Competitive insights
      • 10.3.2.4. U.S. Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.3.3. Canada
      • 10.3.3.1. Key country dynamic
      • 10.3.3.2. Regulatory framework
      • 10.3.3.3. Competitive insights
      • 10.3.3.4. Canada Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.3.4. Mexico
      • 10.3.4.1. Key country dynamic
      • 10.3.4.2. Regulatory framework
      • 10.3.4.3. Competitive insights
      • 10.3.4.4. Mexico Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4. Europe
    • 10.4.1. Europe Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.4.2. Germany
      • 10.4.2.1. Key country dynamic
      • 10.4.2.2. Regulatory framework
      • 10.4.2.3. Competitive insights
      • 10.4.2.4. Germany Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.4.3. UK
      • 10.4.3.1. Key country dynamic
      • 10.4.3.2. Regulatory framework
      • 10.4.3.3. Competitive insights
      • 10.4.3.4. UK Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.4.4. France
      • 10.4.4.1. Key country dynamic
      • 10.4.4.2. Regulatory framework
      • 10.4.4.3. Competitive insights
      • 10.4.4.4. France Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.4.5. Italy
      • 10.4.5.1. Key country dynamic
      • 10.4.5.2. Regulatory framework
      • 10.4.5.3. Competitive insights
      • 10.4.5.4. Italy Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.4.6. Spain
      • 10.4.6.1. Key country dynamic
      • 10.4.6.2. Regulatory framework
      • 10.4.6.3. Competitive insights
      • 10.4.6.4. Spain Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.4.7. Denmark
      • 10.4.7.1. Key country dynamic
      • 10.4.7.2. Regulatory framework
      • 10.4.7.3. Competitive insights
      • 10.4.7.4. Denmark Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.4.8. Sweden
      • 10.4.8.1. Key country dynamic
      • 10.4.8.2. Regulatory framework
      • 10.4.8.3. Competitive insights
      • 10.4.8.4. Sweden Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.4.9. Norway
      • 10.4.9.1. Key country dynamic
      • 10.4.9.2. Regulatory framework
      • 10.4.9.3. Competitive insights
      • 10.4.9.4. Norway Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5. Asia Pacific
    • 10.5.1. Asia Pacific Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.5.2. Japan
      • 10.5.2.1. Key country dynamic
      • 10.5.2.2. Regulatory framework
      • 10.5.2.3. Competitive insights
      • 10.5.2.4. Japan Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.5.3. China
      • 10.5.3.1. Key country dynamic
      • 10.5.3.2. Regulatory framework
      • 10.5.3.3. Competitive insights
      • 10.5.3.4. China Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.5.4. India
      • 10.5.4.1. Key country dynamic
      • 10.5.4.2. Regulatory framework
      • 10.5.4.3. Competitive insights
      • 10.5.4.4. India Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.5.5. South Korea
      • 10.5.5.1. Key country dynamic
      • 10.5.5.2. Regulatory framework
      • 10.5.5.3. Competitive insights
      • 10.5.5.4. South Korea Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.5.6. Australia
      • 10.5.6.1. Key country dynamic
      • 10.5.6.2. Regulatory framework
      • 10.5.6.3. Competitive insights
      • 10.5.6.4. Australia Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.5.7. Thailand
      • 10.5.7.1. Key country dynamic
      • 10.5.7.2. Regulatory framework
      • 10.5.7.3. Competitive insights
      • 10.5.7.4. Thailand Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.6. Latin America
    • 10.6.1. Latin America Precision Medicine Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 10.6.2. Brazil
      • 10.6.2.1. Key country dynamic
      • 10.6.2.2. Regulatory framework
      • 10.6.2.3. Competitive insights
      • 10.6.2.4. Brazil Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.6.3. Argentina
      • 10.6.3.1. Key country dynamic
      • 10.6.3.2. Regulatory framework
      • 10.6.3.3. Competitive insights
      • 10.6.3.4. Argentina Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.7. MEA
    • 10.7.1. MEA Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.7.2. South Africa
      • 10.7.2.1. Key country dynamic
      • 10.7.2.2. Regulatory framework
      • 10.7.2.3. Competitive insights
      • 10.7.2.4. South Africa Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.7.3. Saudi Arabia
      • 10.7.3.1. Key country dynamic
      • 10.7.3.2. Regulatory framework
      • 10.7.3.3. Competitive insights
      • 10.7.3.4. Saudi Arabia Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.7.4. UAE
      • 10.7.4.1. Key country dynamic
      • 10.7.4.2. Regulatory framework
      • 10.7.4.3. Competitive insights
      • 10.7.4.4. UAE Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 10.7.5. Kuwait
      • 10.7.5.1. Key country dynamic
      • 10.7.5.2. Regulatory framework
      • 10.7.5.3. Competitive insights
      • 10.7.5.4. Kuwait Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Participant Overview
  • 11.2. Company Market Position Analysis/Company Market Share Analysis, (2024)
  • 11.3. Company Categorization
  • 11.4. Strategy Mapping
  • 11.5. Company Profiles/Listing
    • 11.5.1. OSP
      • 11.5.1.1. Overview
      • 11.5.1.2. Financial performance
      • 11.5.1.3. Product benchmarking
      • 11.5.1.4. Strategic initiatives
    • 11.5.2. Genomind
      • 11.5.2.1. Overview
      • 11.5.2.2. Financial performance
      • 11.5.2.3. Product benchmarking
      • 11.5.2.4. Strategic initiatives
    • 11.5.3. IQVIA
      • 11.5.3.1. Overview
      • 11.5.3.2. Financial performance
      • 11.5.3.3. Product benchmarking
      • 11.5.3.4. Strategic initiatives
    • 11.5.4. Genedata AG
      • 11.5.4.1. Overview
      • 11.5.4.2. Financial performance
      • 11.5.4.3. Product benchmarking
      • 11.5.4.4. Strategic initiatives
    • 11.5.5. SOPHiA GENETICS
      • 11.5.5.1. Overview
      • 11.5.5.2. Financial performance
      • 11.5.5.3. Product benchmarking
      • 11.5.5.4. Strategic initiatives
    • 11.5.6. Tempus AI, Inc.
      • 11.5.6.1. Overview
      • 11.5.6.2. Financial performance
      • 11.5.6.3. Product benchmarking
      • 11.5.6.4. Strategic initiatives
    • 11.5.7. Owkin, Inc.
      • 11.5.7.1. Overview
      • 11.5.7.2. Financial performance
      • 11.5.7.3. Product benchmarking
      • 11.5.7.4. Strategic initiatives
    • 11.5.8. Syapse (acquired by N-Power in January 2025)
      • 11.5.8.1. Overview
      • 11.5.8.2. Financial performance
      • 11.5.8.3. Product benchmarking
      • 11.5.8.4. Strategic initiatives
    • 11.5.9. Inspirata, Inc.
      • 11.5.9.1. Overview
      • 11.5.9.2. Financial performance
      • 11.5.9.3. Product benchmarking
      • 11.5.9.4. Strategic initiatives
    • 11.5.10. Precision Medicine Group, LLC.
      • 11.5.10.1. Overview
      • 11.5.10.2. Financial performance
      • 11.5.10.3. Product benchmarking
      • 11.5.10.4. Strategic initiatives
    • 11.5.11. Siemens
      • 11.5.11.1. Overview
      • 11.5.11.2. Financial performance
      • 11.5.11.3. Product benchmarking
      • 11.5.11.4. Strategic initiatives
    • 11.5.12. GenomOncology LLC
      • 11.5.12.1. Overview
      • 11.5.12.2. Financial performance
      • 11.5.12.3. Product benchmarking
      • 11.5.12.4. Strategic initiatives
    • 11.5.13. Qserve
      • 11.5.13.1. Overview
      • 11.5.13.2. Financial performance
      • 11.5.13.3. Product benchmarking
      • 11.5.13.4. Strategic initiatives
    • 11.5.14. Foundation Medicine, Inc.
      • 11.5.14.1. Overview
      • 11.5.14.2. Financial performance
      • 11.5.14.3. Product benchmarking
      • 11.5.14.4. Strategic initiatives
    • 11.5.15. PierianDx
      • 11.5.15.1. Overview
      • 11.5.15.2. Financial performance
      • 11.5.15.3. Product benchmarking
      • 11.5.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary data sources
  • Table 3 North America Precision Medicine Software market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 6 North America Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 7 North America Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 8 North America Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 9 North America Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 11 U.S. Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 12 U.S. Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 13 U.S. Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 14 U.S. Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 15 U.S. Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Canada Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 17 Canada Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 18 Canada Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 19 Canada Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 21 Canada Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 22 Mexico Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 23 Mexico Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 24 Mexico Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 25 Mexico Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 26 Mexico Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 27 Mexico Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Europe Precision Medicine Software market, by country, 2021 - 2033 (USD Million)
  • Table 29 Europe Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 30 Europe Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 31 Europe Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 32 Europe Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 33 Europe Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 34 Europe Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Germany Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 36 Germany Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 37 Germany Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 38 Germany Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 39 Germany Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 40 Germany Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 41 UK Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 42 UK Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 43 UK Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 44 UK Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 45 UK Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 46 UK Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 47 France Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 48 France Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 49 France Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 50 France Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 51 France Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 52 France Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Italy Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 54 Italy Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 55 Italy Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 56 Italy Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 57 Italy Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 58 Italy Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Spain Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 60 Spain Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 61 Spain Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 62 Spain Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 63 Spain Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 64 Spain Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Sweden Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 66 Sweden Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 67 Sweden Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 68 Sweden Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 69 Sweden Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 70 Sweden Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Denmark Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 72 Denmark Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 73 Denmark Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 74 Denmark Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 75 Denmark Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 76 Denmark Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Norway Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 78 Norway Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 79 Norway Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 80 Norway Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 81 Norway Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 82 Norway Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 83 Asia Pacific Precision Medicine Software market, by country, 2021 - 2033 (USD Million)
  • Table 84 Asia Pacific Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 85 Asia Pacific Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 86 Asia Pacific Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 87 Asia Pacific Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 88 Asia Pacific Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 89 Asia Pacific Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 90 China Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 91 China Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 92 China Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 93 China Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 94 China Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 95 China Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 96 Japan Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 97 Japan Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 98 Japan Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 99 Japan Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 100 Japan Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 101 Japan Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 102 India Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 103 India Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 104 India Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 105 India Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 106 India Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 107 India Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 108 Australia Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 109 Australia Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 110 Australia Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 111 Austarila Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 112 Austarila Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 113 Australia Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 114 Thailand Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 115 Thailand Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 116 Thailand Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 117 Thailand Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 118 Thailand Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 119 Thailand Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 120 South Korea Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 121 South Korea Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 122 South Korea Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 123 South Korea Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 124 South Korea Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 125 South Korea Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 126 Latin America Precision Medicine Software market, by country, 2021 - 2033 (USD Million)
  • Table 127 Latin America Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 128 Latin America Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 129 Latin America Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 130 Latin America Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 131 Latin America Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 132 Latin America Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 133 Brazil Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 134 Brazil Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 135 Brazil Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 136 Brazil Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 137 Brazil Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 138 Brazil Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 139 Argentina Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 140 Argentina Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 141 Argentina Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 142 Argentina Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 143 Argentina Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 144 Argentina Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 145 MEA Precision Medicine Software market, by country, 2021 - 2033 (USD Million)
  • Table 146 MEA Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 147 MEA Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 148 MEA Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 149 MEA Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 150 MEA Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 151 MEA Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 152 South Africa Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 153 South Africa Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 154 South Africa Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 155 South Africa Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 156 South Africa Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 157 South Africa Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 158 Saudi Arabia Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 159 Saudi Arabia Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 160 Saudi Arabia Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 161 Saudi Arabia Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 162 Saudi Arabia Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 163 Saudi Arabia Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 164 UAE Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 165 UAE Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 166 UAE Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 167 UAE Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 168 UAE Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 169 UAE Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)
  • Table 170 Kuwait Precision Medicine Software market, by component, 2021 - 2033 (USD Million)
  • Table 171 Kuwait Precision Medicine Software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 172 Kuwait Precision Medicine Software market, by application, 2021 - 2033 (USD Million)
  • Table 173 Kuwait Precision Medicine Software market, by technology, 2021 - 2033 (USD Million)
  • Table 174 Kuwait Precision Medicine Software market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 175 Kuwait Precision Medicine Software market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Precision Medicine Software market: Market outlook
  • Fig. 5 Precision Medicine Software market: Segment outlook
  • Fig. 6 Precision Medicine Software market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Precision Medicine Software Market Driver Impact
  • Fig. 9 Precision Medicine Software Market Restraint Impact
  • Fig. 10 Precision Medicine Software Market, Component outlook key takeaways (USD Million)
  • Fig. 11 Precision Medicine Software Market: Component movement analysis (USD Million)
  • Fig. 12 Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Implementation & integration market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Clinical interpretation & reporting services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Validation & regulatory support market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Data curation / annotation services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Precision Medicine Software Market, deployment mode outlook key takeaways (USD Million)
  • Fig. 20 Precision Medicine Software Market: deployment mode movement analysis, (USD Million)
  • Fig. 21 Cloud Based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 On-Premise market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Precision Medicine Software Market, application outlook: Key takeaways, (USD Million)
  • Fig. 24 Precision Medicine Software Market: application movement analysis, (USD Million)
  • Fig. 25 Genomic Data Management & Analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Multi-omics Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Clinical Decision Support & Treatment Planning market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Companion Diagnostics & Biomarker Discovery Tools market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Clinical Trial Matching & Site Selection market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others (Population Genomics / Public-health Precision Tools) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Precision Medicine Software Market, technology outlook key takeaways (USD Million)
  • Fig. 32 Precision Medicine Software Market technology movement analysis, (USD Million)
  • Fig. 33 AI / Machine Learning models & Generative AI market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Rule-based engines (clinical guidelines, pathways) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Cloud & Containerized Pipelines (Kubernetes/Docker) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 High-performance compute / HPC for genomics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Interoperability / FHIR / HL7 integration market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others (Data lakes & MDM (multi-modal data stores)) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Precision Medicine Software Market, therapeutic area outlook key takeaways (USD Million)
  • Fig. 40 Precision Medicine Software Market: therapeutic area movement analysis, (USD Million)
  • Fig. 41 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Cardiology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Neurology/CNS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Rare & Genetic Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Infectious Diseases (pathogen genomics) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Immunology/Autoimmune market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Others (dermatology, endocrinology) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Precision Medicine Software Market, end use outlook key takeaways (USD Million)
  • Fig. 49 Precision Medicine Software Market: end use movement analysis, (USD Million)
  • Fig. 50 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Pharmaceutical & Biotech companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Diagnostic Laboratories & Genomic Service Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Contract Research Organizations (CROs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Others (Research Institutes & Academic Centers) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 Precision Medicine Software market: Regional outlook, 2024 & 2033
  • Fig. 57 North America Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 U.S. Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Canada Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Mexico Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Europe Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 UK Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Germany Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 France Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Italy Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Spain Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Denmark Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Sweden Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Norway Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Japan Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 China Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 India Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 South Korea Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Australia Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Thailand Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Brazil Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Argentina Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 MEA Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 South Africa Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 UAE Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Kuwait Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)